163 related articles for article (PubMed ID: 31425514)
1. Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand.
He WQ; Karl S; White MT; Nguitragool W; Monteiro W; Kuehn A; Gruszczyk J; França CT; Sattabongkot J; Lacerda MVG; Tham WH; Mueller I
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007596. PubMed ID: 31425514
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children.
França CT; He WQ; Gruszczyk J; Lim NT; Lin E; Kiniboro B; Siba PM; Tham WH; Mueller I
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005014. PubMed ID: 27677183
[TBL] [Abstract][Full Text] [Related]
3. Naturally Acquired Human Antibodies Against Reticulocyte-Binding Domains of Plasmodium vivax Proteins, PvRBP2c and PvRBP1a, Exhibit Binding-Inhibitory Activity.
Gupta ED; Anand G; Singh H; Chaddha K; Bharti PK; Singh N; Sharma YD; Gaur D
J Infect Dis; 2017 May; 215(10):1558-1568. PubMed ID: 28379500
[TBL] [Abstract][Full Text] [Related]
4. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
[TBL] [Abstract][Full Text] [Related]
5. Comparison of total immunoglobulin G antibody responses to different protein fragments of Plasmodium vivax Reticulocyte binding protein 2b.
Bourke C; Takashima E; Chan LJ; Dietrich MH; Mazhari R; White M; Sattabongkot J; Tham WH; Tsuboi T; Mueller I; Longley R
Malar J; 2022 Mar; 21(1):71. PubMed ID: 35246142
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand.
Longley RJ; França CT; White MT; Kumpitak C; Sa-Angchai P; Gruszczyk J; Hostetler JB; Yadava A; King CL; Fairhurst RM; Rayner JC; Tham WH; Nguitragool W; Sattabongkot J; Mueller I
Malar J; 2017 Apr; 16(1):178. PubMed ID: 28454546
[TBL] [Abstract][Full Text] [Related]
7. Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.
Nicolete VC; Frischmann S; Barbosa S; King CL; Ferreira MU
J Infect Dis; 2016 Nov; 214(10):1539-1546. PubMed ID: 27578850
[TBL] [Abstract][Full Text] [Related]
8. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
[TBL] [Abstract][Full Text] [Related]
10. Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil.
Costa EMF; Amador ECC; Silva ES; Alvarenga CO; Pereira PE; Póvoa MM; Cunha MG
Acta Trop; 2020 Sep; 209():105537. PubMed ID: 32454033
[TBL] [Abstract][Full Text] [Related]
11. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
[TBL] [Abstract][Full Text] [Related]
12. Naturally induced humoral response against Plasmodium vivax reticulocyte binding protein 2P1.
Hietanen J; Chim-Ong A; Sattabongkot J; Nguitragool W
Malar J; 2021 Jun; 20(1):246. PubMed ID: 34082763
[TBL] [Abstract][Full Text] [Related]
13. The presence of circulating antibody secreting cells and long-lived memory B cell responses to reticulocyte binding protein 1a in Plasmodium vivax patients.
Kochayoo P; Sanguansuttikul P; Thawornpan P; Wangriatisak K; Adams JH; Ntumngia FB; Chootong P
Malar J; 2021 Dec; 20(1):474. PubMed ID: 34930312
[TBL] [Abstract][Full Text] [Related]
14. Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b.
Chan LJ; Gandhirajan A; Carias LL; Dietrich MH; Vadas O; Visentin R; França CT; Menant S; Soldati-Favre D; Mueller I; King CL; Tham WH
Nat Commun; 2021 Mar; 12(1):1538. PubMed ID: 33750786
[TBL] [Abstract][Full Text] [Related]
15. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
[TBL] [Abstract][Full Text] [Related]
16. Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand.
Longley RJ; Reyes-Sandoval A; Montoya-Díaz E; Dunachie S; Kumpitak C; Nguitragool W; Mueller I; Sattabongkot J
Clin Vaccine Immunol; 2016 Feb; 23(2):117-24. PubMed ID: 26656115
[TBL] [Abstract][Full Text] [Related]
17. High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.
Versiani FG; Almeida ME; Melo GC; Versiani FO; Orlandi PP; Mariúba LA; Soares LA; Souza LP; da Silva Balieiro AA; Monteiro WM; Costa FT; del Portillo HA; Lacerda MV; Nogueira PA
Malar J; 2013 Aug; 12():294. PubMed ID: 23977965
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.
He WQ; Shakri AR; Bhardwaj R; França CT; Stanisic DI; Healer J; Kiniboro B; Robinson LJ; Guillotte-Blisnick M; Huon C; Siba P; Cowman A; King CL; Tham WH; Chitnis CE; Mueller I
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0006987. PubMed ID: 30768655
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon.
Ferreira AR; Singh B; Cabrera-Mora M; Magri De Souza AC; Queiroz Marques MT; Porto LC; Santos F; Banic DM; Calvo-Calle JM; Oliveira-Ferreira J; Moreno A; Lima-Junior JC
PLoS One; 2014; 9(8):e105828. PubMed ID: 25148251
[TBL] [Abstract][Full Text] [Related]
20. IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.
França CT; Li Wai Suen CSN; Carmagnac A; Lin E; Kiniboro B; Siba P; Schofield L; Mueller I
Malar J; 2017 Sep; 16(1):386. PubMed ID: 28946883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
